Astrazeneca PLC News Headlines

AZN 
$70.91
*  
0.47
0.67%
Get AZN Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading AZN now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
The Newest FDA-Approved Obesity Drug Is Also the Oldest
12/27/2014 8:04:04 AM - Motley Fool


Update: Myriad Genetics Won FDA Approval For BRACAnalysis CDx
12/25/2014 11:53:00 AM - Seeking Alpha


AQR Capital sold its position in AstraZeneca
12/25/2014 10:59:00 AM - Market Realist


AQR Capital increases position in Biogen Idec
12/25/2014 8:59:00 AM - Market Realist


AQR Capital ups position in Glimcher Realty Trust
12/24/2014 4:59:00 PM - Market Realist


AQR Capital increases stake in Intel
12/24/2014 2:59:00 PM - Market Realist


Myriad Genetics' Ovarian Cancer Test Wins FDA Approval - Analyst Blog
12/24/2014 2:10:00 PM - Investopedia


Myriad Genetics' Ovarian Cancer Test Wins FDA Approval - Analyst Blog
12/24/2014 2:10:00 PM - Zacks.com


AQR Capital ups position in Shire Plc
12/24/2014 12:59:00 PM - Market Realist


European ADRs Lifted by Pharmaceutical Stock Gains
12/24/2014 10:50:19 AM - MT Newswires


The Global Defenders
12/24/2014 1:25:00 AM - Seeking Alpha


AQR Capital initiated position in Bally Technologies Inc.
12/23/2014 10:00:00 PM - Market Realist


AQR Capital Management’s 3Q14 positions
12/23/2014 9:59:00 PM - Market Realist


European ADRs Lower on Pharmaceutical Stock Contraction
12/23/2014 11:19:48 AM - MT Newswires


AstraZeneca's Lynparza Cleared in U.S. for Ovarian Cancer - Analyst Blog
12/22/2014 5:45:00 PM - Zacks.com


3 Drugmakers Facing a Pivotal 2015
12/22/2014 11:41:02 AM - Motley Fool


Buying These 3 Stocks Is Like Making a Bet in a Burning House
12/22/2014 8:54:02 AM - Motley Fool


AstraZeneca's Lynparza Cleared in U.S. for Ovarian Cancer - Analyst Blog
12/22/2014 5:45:00 AM - Investopedia


European Stocks Seen Rising As Crude Extends Gains
12/22/2014 2:01:00 AM - RTT News


JAZZ Hits Right Note, ENTA's Purse Set To Fatten, AEZS Put On Notice
12/21/2014 11:36:00 PM - RTT News


Update: In A Surprise Twist, AstraZeneca Wins Accelerated FDA Approval For Lynparza
12/21/2014 4:32:00 PM - Seeking Alpha


Why Is George Soros Buying This Beaten Down Biotech Stock?
12/21/2014 11:04:03 AM - Motley Fool


Drug Giants Face $65 Billion in Lost Sales as Insurers Attack Patents
12/21/2014 9:01:02 AM - Motley Fool


Actavis Considers Offer For Almirall : Report
12/20/2014 3:53:00 PM - RTT News


A New Study on Diabetes Reveals Potentially Frightening News
12/20/2014 11:41:02 AM - Motley Fool